# Scinai Immunotherapeutics Enters Financing Agreements for About $4 Million

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/31795
Published: 2026-10-14T12:38:09.000Z
Updated: 2026-10-14T12:38:09.000Z
Section: Business

> The agreements cover 2.46 million American depositary shares or pre-funded warrants, plus warrants for up to 3.69 million additional shares.

Scinai Immunotherapeutics (SCNI) entered financing agreements for approximately $4 million in gross proceeds, combining American depositary shares or pre-funded warrants with warrants for additional shares.

The agreements cover 2.46 million American depositary shares (ADSs) or pre-funded warrants. Series A-1 warrants give holders the right to purchase up to 3.69 million more ADSs.

The agreements were announced Oct. 14, 2026.